ST7 isoform b, into BamHI-EcoRI-linearized pGex-2TK. The 5' primer was modified by introducing a BamHI restriction site (5'CGCGGATCCTTAATCCTACCCCCAGAACATATC3'), while the 3' primer included an EcoRI restriction site (5'CCGGAATTCTCAGTTTTGGAAATGTTGAGATTG3'). Full-length ST7 cDNA was PCR-amplified from pSuperscript human liver cDNA library (Invitrogen, Inc.) using a 5' primer containing a BamHI restriction site (5'CGCGGATCCCCGGGCCGGTGAATCATCCCGGCAGACA3') and a 3' primer (5'CCGGAATTCGAAGAGGGGTGATGAGTTCAGTTTTG3') including an EcoRI restriction site, and cloned in BamHI-EcoRI-linearized pBS(KS+). Plasmid pCMVLuc/PRMT5-3'UTR was generated by inserting the 3'UTR of PRMT5 (nucleotide [nt] 1871 to 2248) as a blunt end PCR fragment into SalI-linearized and klenow treated pCMV-Luc. To mutate the miR-92b and miR-96 binding sites, pCMV-Luc/PRMT5-2 3'UTR were used as a template in a Quick Change multisite directed mutagenesis reaction as specified by the manufacturer (Stratagene, Inc.). To mutate the underlined miR-92b or miR-96 seed sequence binding site, two distinct primers were used (5'-GAAGCAGCTTCAGGTTCCTGCTCCTGTAGTACAGAAGCATAGGACCATCTAT GGGCTGTGATTCCCCCTTGCCCATCAGAG-3') and (5'-CTAAAGGGGGCCCTGCGAAGATAGTGTCCAGAGCCTTGG-3'), respectively. To generate a vector for lentiviral expression of anti-sense PRMT5, pRRLsin.hCMV-puro /AS-PRMT5 was constructed by inserting a 2.1 kbp sticky-blunt BamHI-ClaI DNA fragment from pBabe/AS-PRMT5, which contains a 1 kbp AS-PRMT5 sequence and an SV40-driven puromycin marker, into sticky-blunt BamHI-SalI-linearized pRRLsin.hCMVIRESGFP. As a control empty vector, a 1.1 kbp sticky-blunt BamHIClaI DNA fragment containing SV40-driven puromycin was inserted into sticky-blunt BamHI-SalI-linearized pRRLsin.hCMVIRESGFP.
B cell isolation
To isolate normal B cells, tonsilar tissues were minced extensively in RPMI-1640 containing 10% FBS and strained through a collector sieve (Bellco Glass, Inc.) to remove tissue debris. Next, monocytes were removed by adhesion to tissue culture plates, and B cells were isolated by depletion of T lymphocytes. Cells were mixed with 8-fold excess of sheep red blood cells (Colorado Serum Company) and incubated on ice for 1 hr. To separate B cells from rosetted T lymphocytes, 10 ml of ficoll-paque (Amersham, Inc.) was added, and samples were spun at room temperature before collecting the layer containing B cells. B lymphocytes were washed with media and purity of the isolated 3 cells was determined by FACS analysis using anti-CD19-PE antibody. B lymphocytes isolated by this procedure were 90-95% pure.
Transfection of normal and transformed B lymphocytes, and luciferase assays
To evaluate the effects of miR-92b and mir-96 on PRMT5 protein expression, either wild type or mutant miR-92b and miR-96 specific dsRNA was electroporated into JeKo and 15 mg of total DNA (6 mg of pCMV-Luc construct, 2 mg of pRenilla-Luc control plasmid, and 7 mg of pBS(KS+)) in 100 ml of appropriate nucleofector reagent. After electroporation cells were plated in 3 ml RPMI-1640 containing 10% FBS for 24 hr, and then lysed in 100 ml of 1X passive lysis buffer. Dual luciferase reporter analysis was carried out using 40 ml of cell lysate as specified by the manufacturer (Promega, Inc.).
Generation of lentiviral particles and infection of JeKo and Raji cells.
To prepare lentiviral particles containing either empty vector or anti-sense (AS) PRMT5, 40% confluent 293T cells were transfected with 5 mg of pVSV-G, 15 mg of pCMVD8.2 and 20 mg of either pRRL-puro or pRRL-AS-PRMT5 using the calcium phosphate precipitation protocol (Sambrook et al., 1989) . Supernatants containing replicationdeficient lentivirus were harvested 48 hr post-transfection and clarified by centrifugation at 2,000 rpm for 4 min. To knockdown PRMT5 expression, 7.5 x 10 5 JeKo and Raji cells were infected with 250 ml of either control empty vector or AS-PRMT5 lentivirus supernatant in a final volume of 1 ml RPMI-1640 supplemented with 10% FBS containing 8 mg of polybrene for 48 hr before changing the medium. To monitor proliferation, infected cells were counted every 2 days for 6 days post-infection from four different infections.
Antibodies, Western blot and immunofluorescence analyses
BRG1, BRM, PRMT5, H3(Me 2 )R8 and BAF57 antibodies were described previously (Sif et al., 1998 , Sif et al., 2001 , Pal et al., 2004 . Rabbit polyclonal anti-ST7 antibody was generated using GST-ST7 fusion protein (aa 325-585) (Covance, Inc.). To generate anti-H4(Me 2 )R3 antibody, a synthetic peptide containing symmetrically methylated H4 arginine 3 was used to immunize rabbits (Covance, Inc.). Western blots were performed using nuclear, cytosolic, or whole cell extracts. Nuclear and cytosolic extracts were prepared as described previously (Li et al., 1991) . For whole cell extracts, 1 x 10 7 cells
were lysed in 150 ml of RIPA lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
NP-40, 0.1% SDS and 0.5% sodium deoxycholate) on ice for 20 min, and cell lysates were clarified by centrifugation. Proteins were separated by 8-10% SDS-PAGE, transferred to nitrocellulose membrane and detected by enhanced chemiluminescence.
For immunofluorescence experiments, PRMT5, ST7, H3(Me 2 )R8, and H4(Me 2 )R3 were visualized by plating 1 x 10 4 cells on glass coverslips, which were pretreated with poly-Llysine. The next day, cells were washed with phosphate buffered saline (PBS), fixed in 4% paraformaldehyde for 15 min at room temperature, and treated with 0.1% Triton X-100 for 10 min at room temperature. Cells were then blocked in 10% goat serum for 2 hr, washed with PBS, and incubated with either preimmune, anti-PRMT5, anti-ST7, affinity purified H3(Me 2 )R8, or anti-H4(Me 2 )R3 antibody for 2 hr at 37 0 C. To remove excess primary antibody, cells were washed extensively with PBS before incubating with FITClabeled goat anti-rabbit antibody for 1 hr at 37 0 C. Cells were washed again with PBS, and nuclei were stained with DAPI (0.2 mg/ml) for 5 min at room temperature before coverslips were mounted using prolong antifade reagent (Molecular probes, Inc.). 6 PRMT5, ST7, and symmetrically methylated H3R8 and H4R3 proteins were visualized by fluorescence microscopy using a Zeiss axioscope at 100X magnification.
Reverse transcription and real time PCR
Reverse transcription (RT) was performed on 2 mg of total RNA, isolated with Trizol reagent, using a reverse transcription kit (Applied Biosystems, Inc.). Briefly, 20 ml reaction containing 2 mg RNA, 1X TaqMan RT buffer, 5.5 mM MgCl 2 , 0.5 mM dNTP's, 2.5 mM random hexamer, 0.4 U/ml RNase inhibitor, and 1.25 U/ml multiscribe reverse transcriptase was first incubated for 10 min at 25 0 C followed by incubation for 1 hr at 42 0 C, and next the reaction was inactivated for 5 min at 95 0 C. Real time PCR was performed using the TaqMan system (Applied Biosystems, Inc.) in a 10 ml reaction Following hybridization, the blot was washed twice in 6X SSPE containing 0.2% SDS for 30 min at 42 0 C and analyzed by phosphorImager.
Polyribosome profiling
Approximately 8 x 10 7 normal B or 1 x 10 7 MCL cells were washed twice with PBS and lysed in 250 ml of lysis buffer (20 mM HEPES [pH 7.5], 100 mM KCl, 10 mM MgCl 2 , 0.25% NP-40, 100 mg/ml cycloheximide, 100 U/ml RNasin, 1 mM DTT, and protease inhibitors) by passing through a 27.5 gauge needle five times. Lysates were loaded onto a linear 15%-40% sucrose gradient (4.8 ml) and centrifuged in a SW55 rotor at 43,000 rpm for 2.5 hr at 4 0 C. Fractions were collected and absorbance of each fraction (~ 200 ml) was measured at 254 nm before total RNA was extracted using Trizol reagent.
PRMT5 mRNA levels were measured by real time RT-PCR, and as an internal control b-ACTIN mRNA levels were also determined.
RNase protection assay (RPA)
To detect expression of miRNAs, RPA was performed on 20 mg of total RNA isolated from either normal B lymphocytes or transformed MCL cell lines. Labeled probes were constructed using the mirVana miRNA probe construction kit (Ambion, Inc.).
Essentially, a single stranded DNA oligonucleotide corresponding to the desired miR sequence and containing the T7 promoter sequence at the 3'end was hybridized to the T7 promoter primer, and extended using Klenow DNA polymerase for 30 min at 37 0 C. The 9 resulting double stranded (ds) DNA template was in vitro transcribed using T7 RNA polymerase in the presence of either [a-P 32 ]CTP or [a-P 32 ]UTP for 30 min at 37 0 C.
Transcription was terminated by adding DNase I to the reaction, and labeled RNA was purified by loading samples onto a 12% acrylamide-urea gel. Labeled full-length RNA probe was excised out and eluted from the gel as specified by the manufacturer. To measure the level of each miRNA, RPA was performed using the mirVana miRNA detection kit (Ambion, Inc.). Briefly, 5 x 10 4 cpm of each miR-specific probe was mixed with 20 mg of total RNA in the presence of mirVana hybridization buffer, heat denatured, and then incubated for 16 hr at 42 0 C. As a control, miR-specific probes were also incubated with 20 mg of yeast tRNA. Next, reactions were digested with 1:100 dilution of RNase A+T1 in 150 ml of RNase digestion buffer for 45 min at 37 0 C. To inactivate RNase A+T1 and to precipitate protected dsRNA, 225 ml of RNase Inactivation/PPT solution and 225 ml of 100% ethanol were added to each reaction, mixed, and incubated for 2 hr at -80 0 C. Protected dsRNA was harvested by centrifugation and pellets were resuspended in gel loading bufferII. Samples were boiled and loaded onto a 15%
acrylamide-urea gel pre-run for 1 hr at 15 A. Protected RNAs were visualized by phosphorImaging, and quantitated using ImageQuant v5.0.
In vitro transcription, capping, polyadenylation, and translation
PRMT5 with or without wild type 3'UTR and BAF45 cDNAs were in vitro transcribed and capped simultaneously using 1 mg of EcoRV-linearized pBS(KS+)-based constructs using T7 RNA polymerase with the message machine kit for 2 hr at 37 0 C (Ambion, Inc.).
Next, polyadenylation was carried out in a 100 ml reaction containing 20 ml transcription mRNA expression was normalized to GAPDH.
